BacAlt Biosciences Secures $2 Million for Innovative Bio-Based Solutions

BacAlt Biosciences, a pioneering bio-tech startup, has successfully raised $2 million (approximately Rs 18 crore) in a pre-seed funding round. The investment was led by Avaana Capital, with additional support from Lubrizol InnoVentures. The current valuation of BacAlt stands at $8 million.

The funds are earmarked for enhancing research and development processes, constructing pilot production facilities, expanding the workforce, and formulating strategies for geographic market entry, as stated in a recent press release from BacAlt Biosciences.

About BacAlt Biosciences

Founded in 2023 by Shruti Kutmutia and Pranav Nair, BacAlt is focused on creating bio-based polymers and specialty ingredients. The company employs lean, energy-efficient methods alongside high-throughput fermentation to boost product performance across various applications while tackling the issue of microplastic pollution. This Bengaluru-based startup strategically utilises waste valorisation, circular feedstocks, and non-sterile fermentation techniques.

Vision and Goals

According to Shruti Kutmutia, the Co-Founder of BacAlt, the company’s vision is to establish India as a prominent hub for circular, bio-based specialty ingredients. She emphasised that there is a genuine demand for high-performance, cost-competitive ingredients. BacAlt is dedicated to scaling operations and transforming India from an import-reliant market to a bio-manufacturing powerhouse ready for export.

Innovative Solutions

By integrating advancements in microbiology, industrial biomanufacturing, and scalable fermentation techniques, BacAlt Biosciences aims to produce dependable, high-performance alternatives to petrochemical-derived ingredients. This innovation is set to redefine the future of formulations globally.